Sees Q3 adjusted EBITDA $65M-$70M.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ASTH:
- Astrana Health price target lowered to $50 from $70 at BTIG
- Astrana Health’s Strategic Acquisition and Financial Guidance Boost: Analyst Recommends Buy
- Astrana Health Completes Acquisition of Prospect Health
- Astrana Health management to meet with Truist
- Astrana Health Approves 2024 Equity Incentive Plan